Development of polymeric micelles loaded with STAT3 inhibitory, Stattic, for cancer treatment
Background. STAT3 is an oncogenic signaling pathway found constitutively active in many types of human malignancies and plays a key role in cancer progression. Stattic is a small molecule, which selectively inhibits the SH2 domain of STAT3. In most studies, stattic has been proposed as a promising s...
Main Authors: | Hamed Masoumzadeh, Nasrin Hoseinzad, Sevda Jafari, Ali Shayanfar, Haleh Vaez, Ommoleila Molavi |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tabriz University of Medical Sciences
2021-10-01
|
Series: | مجله پزشکی دانشگاه علوم پزشکی تبریز |
Subjects: | |
Online Access: | https://mj.tbzmed.ac.ir/PDF/mj-43-335.pdf |
Similar Items
-
Improvement of Docetaxel Efficacy through Simultaneous Blockade of Transcription Factors NF-κB and STAT-3 Using Pentoxifylline and Stattic in Prostate Cancer Cells
by: José Roberto Cruz-Lozano, et al.
Published: (2024-09-01) -
Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs
by: Changlin Xu, et al.
Published: (2024-05-01) -
Chitosan-Coated-PLGA Nanoparticles Enhance the Antitumor and Antimigration Activity of Stattic – A STAT3 Dimerization Blocker
by: Fong SS, et al.
Published: (2022-01-01) -
Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin
by: Ashkan Hassankhani Rad, et al.
Published: (2020-03-01) -
Carbazole Derivatives as STAT Inhibitors: An Overview
by: Anna Caruso, et al.
Published: (2021-07-01)